drugset / Trial / NCT00684866
Safety and Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Pediatrics Subjects With Asthma
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to compare the safety and tolerability of levalbuterol HFA metered dose inhaler (MDI) versus racemic albuterol HFA MDI in pediatric subjects 4-11 years of age with asthma
Timeline
- Start
- 2003-01
- Primary completion
- 2003-07
- Completion
- 2003-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levalbuterol | Other / unclassified | 45 ug | Inhaled |
| Subject | racemic albuterol | Unknown | 90 ug | Inhaled |